Gene‐Engineered Cerium‐Exosomes Mediate Atherosclerosis Therapy Through Remodeling of the Inflammatory Microenvironment and DNA Damage Repair
Small · 2024-11 · 20 (46)
DOI: 10.1002/smll.202404463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 05.09.2024. Verfasst von Peng Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, P. R. Ch…. Hauptthemen laut MEDLINE: Atherosclerosis, Cerium, Exosomes, DNA Repair. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research Program of Shanghai Sixth People's Hospital, Shanghai Pujiang Program, Postdoctoral Fellowship Program of China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The pro‐inflammatory immune microenvironment in the localized lesion areas and the absence of DNA damage repair mechanisms in endothelial cells serve as essential accelerating factors in the development of atherosclerosis. The lack of targeted therapeutic strategies represents a significant limitation in the efficacy of therapeutic agents for atherosclerosis. In this study, Genetically engineered SNHG12‐loaded cerium‐macrophage exosomes (Ce‐Exo) are designed as atherosclerosis‐targeting agents. In vivo studies demonstrated that Ce‐Exo exhibited multivalent targeting properties for macrophages, with a 4.1‐fold higher atherosclerotic plaque‐aggregation ability than that of the control drugs. This suggests that Ce‐Exo has a higher homing capacity and deeper penetration into the atherosclerotic plaque. In apolipoprotein E‐deficient mice, Ce‐Exo found to effectively remodel the immune microenvironment in the lesion area, repair endothelial cell damage, and inhibit the development of atherosclerosis. This study provides a novel approach to the treatment of atherosclerosis and demonstrates the potential of cell‐derived drug carriers in biomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, P. R. China.
- Department of Emergency Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, P. R. China.
- Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, P. R. China.
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, 201800, P. R. China.
- School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, P. R. China.
- Department of Ultrasound in Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, P. R. China.
ORCID-Profile: Qiang Zhang, Lixian Jiang, Yuxuan Qian, Yimu Fu
Förderung
- Research Program of Shanghai Sixth People's Hospital
- Shanghai Pujiang Program
- Postdoctoral Fellowship Program of China Postdoctoral Science Foundation
Zitieren
APA
Wei, P., Wang, Y., Feng, H., Zhang, F., Ji, Z., Zhang, K., Zhang, Q., Jiang, L., Qian, Y., & Fu, Y. (2024). Gene‐Engineered Cerium‐Exosomes Mediate Atherosclerosis Therapy Through Remodeling of the Inflammatory Microenvironment and DNA Damage Repair. Small, 20(46). https://doi.org/10.1002/smll.202404463
Vancouver
Wei P, Wang Y, Feng H, Zhang F, Ji Z, Zhang K, et al. Gene‐Engineered Cerium‐Exosomes Mediate Atherosclerosis Therapy Through Remodeling of the Inflammatory Microenvironment and DNA Damage Repair. Small. 2024;20(46). doi:10.1002/smll.202404463
BibTeX
@article{Wei2024,
author = {Wei, Peng and Wang, Yifan and Feng, Haiyan and Zhang, Fan and Ji, Zhenyan and Zhang, Kai and Zhang, Qiang and Jiang, Lixian and Qian, Yuxuan and Fu, Yimu},
title = {Gene‐Engineered Cerium‐Exosomes Mediate Atherosclerosis Therapy Through Remodeling of the Inflammatory Microenvironment and DNA Damage Repair},
journal = {Small},
year = {2024},
volume = {20},
number = {46},
doi = {10.1002/smll.202404463}
}
EUVIMED